Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nyxoah (NYXH) Inventory (2020 - 2025)

Nyxoah's quarterly Inventory came in at $5.4 million in Q4 2025, up 7.64% year-on-year from $5.0 million in Q4 2024, and up 7.64% quarter-over-quarter from $5.0 million in Q4 2024.

Nyxoah has reported Inventory for 6 years, with the latest figure at $5.4 million in Q4 2025.

  • For the quarter ending Q4 2025, Inventory rose 7.64% year-over-year to $5.4 million; the trailing twelve-month figure through Dec 2025 stood at $5.4 million (up 7.64% YoY), and the FY2025 full-year result was $5.4 million, up 7.64% from the prior year.
  • Inventory for Q4 2025 stood at $5.4 million, up from $5.0 million in the prior quarter.
  • The five-year high for Inventory was $5.4 million in Q4 2025, with the low at $395813.9 in Q4 2021.
  • Average Inventory over 5 years is $3.1 million, with a median of $3.6 million recorded in 2023.
  • Year-over-year, Inventory surged 503.6% in 2021 and increased 7.64% in 2025.
  • Tracing NYXH's Inventory over 5 years: stood at $395813.9 in 2021, then jumped by 127.34% to $899858.2 in 2022, then surged by 296.37% to $3.6 million in 2023, then surged by 41.29% to $5.0 million in 2024, then increased by 7.64% to $5.4 million in 2025.
  • The last three Inventory figures came in at $5.4 million (Q4 2025), $5.0 million (Q4 2024), and $3.6 million (Q4 2023), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Inventory (Qtr)
1 Intuitive Surgical 156.17 Bn 151.78 Bn 1.83 Bn 1.95 Bn
2 Becton Dickinson 41.51 Bn 40.49 Bn 2.15 Bn 3.36 Bn
3 Resmed 30.43 Bn 28.77 Bn 890.98 Mn 911.88 Mn
4 West Pharmaceutical Services 22.78 Bn 22.26 Bn 296.40 Mn 452.60 Mn
5 Solventum 13.39 Bn 13.39 Bn 1.10 Bn 1.09 Bn
6 Cooper Companies 12.33 Bn 12.20 Bn 695.20 Mn 876.40 Mn
7 Align Technology 11.65 Bn 10.59 Bn 736.59 Mn 214.94 Mn
8 Baxter International 9.81 Bn 7.77 Bn 891.00 Mn 2.32 Bn
9 Aptargroup 7.39 Bn 7.19 Bn 351.91 Mn 551.48 Mn
10 Nyxoah 1,248.49 1,248.49 4.26 Mn -

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 5.42 Mn
Dec 31, 2024 5.04 Mn
Dec 31, 2023 3.57 Mn
Dec 31, 2022 899,858.18
Dec 31, 2021 395,813.95
Dec 31, 2020 65,575.94